# RIGEL PHARMACEUTICALS INC (RIGL) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from RIGEL PHARMACEUTICALS INC's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/RIGL/mda/fy2025/): filed 2026-03-03; accession 0001034842-26-000015 (https://www.sec.gov/Archives/edgar/data/1034842/000103484226000015/rigl-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/RIGL/mda/fy2024/): filed 2025-03-04; accession 0001558370-25-002169 (https://www.sec.gov/Archives/edgar/data/1034842/000155837025002169/rigl-20241231x10k.htm)
- [FY 2023 MD&A](/company/RIGL/mda/fy2023/): filed 2024-03-05; accession 0001558370-24-002475 (https://www.sec.gov/Archives/edgar/data/1034842/000155837024002475/rigl-20231231x10k.htm)
- [FY 2022 MD&A](/company/RIGL/mda/fy2022/): filed 2023-03-07; accession 0001558370-23-003035 (https://www.sec.gov/Archives/edgar/data/1034842/000155837023003035/rigl-20221231x10k.htm)
- [FY 2021 MD&A](/company/RIGL/mda/fy2021/): filed 2022-03-01; accession 0001558370-22-002551 (https://www.sec.gov/Archives/edgar/data/1034842/000155837022002551/rigl-20211231x10k.htm)

Back to /company/RIGL/